We stained serial sections with 6 antibodies alternating with stainings for A and p-Tau routinely used for AD diagnosis, to be able to perform correlation analysis later on
Given that the Phase I clinical trial in IPF demonstrated a reduction of senescent cells and SASP within eleven days after a single treatment of D+Q, and improvements in physiological outcomes after 10 weeks (105), we reasoned that a three-month period would provide important feasibility, compliance and efficacy data, as well as potentially reveal other cognitive and biomarker effects useful for designing a larger study
These bioactive compoundsnaturally occurring or scientifically synthesizedboost collagen and elastin production, promoting firmer, plumper, and smoother skin
doi: 10.1038/s41467-019-14151-9 85 GargSKYanZVitvitskyVBanerjeeR
GLP-1 receptor agonist medications are prescription medications that require evaluation and monitoring by a licensed healthcare provider